Source: Contract Pharma

Fareva Richmond: Fareva, ApiJect Sign 10-Year Blow-Fill-Seal Licensing Agreement

Invests $56.5M to fill-finish more than 500 million doses per year of vaccines and other large molecule injectable drugs using ApiJect's technology.

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
10-50K
Bernard Fraisse's photo - President & CEO of Fareva Richmond

President & CEO

Bernard Fraisse

CEO Approval Rating

53/100

Read more